Clinical Drug Experience Knowledgebase

Acute Coronary Syndrome (Phase 2)

Chronic Disease (Phase 3)

Communicable Diseases (Phase 2)

Complex Regional Pain Syndromes (Phase 3)

Coronavirus Infections (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Diabetes Mellitus, Type 2 (Phase 2)

Familial Primary Pulmonary Hypertension (Phase 2)

Glioblastoma (Phase 3)

Hodgkin Disease (Phase 4)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Infections (Phase 2)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 1)

Leukemia (Phase 3)

Leukemia, Hairy Cell (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Lymphoma (Phase 4)

Lymphoma, B-Cell, Marginal Zone (Phase 3)

Lymphoma, Mantle-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Myalgia (Phase 1)

Pelvic Pain (Phase 3)

Pneumonia (Phase 2)

Polyomavirus Infections (Phase 4)

Prostatitis (Phase 3)

Pyelonephritis (Phase 2)

Reflex Sympathetic Dystrophy (Phase 3)

Respiratory Aspiration (Phase 2)

Sepsis (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Somatoform Disorders (Phase 3)

ST Elevation Myocardial Infarction (Phase 2)

Syndrome (Phase 3)

Urinary Tract Infections (Phase 2)

Virus Diseases (Phase 2)